Bioinspired Anti‐VEGF Peptide Nanoparticle with Immune Regulating and Corneal Epithelium Penetration Capability for Corneal Neovascularization Therapy

View at publisher Summarise with VIRAT
Authors: Wei Hu, Xueqi Lin, Jiaxi Xu, Bingbing Yao, Jinhui Dai, Min Sun, Zhen Fan
Cited by: 0
References: 50

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Corneal neovascularization (CorNV), a leading cause of blindness, is notoriously difficult to treat because of the cornea's tight epithelial barrier and the accompanying inflammatory environment. Current therapies suffer from poor penetration and inadequate management of inflammation. To overcome these challenges, we developed a novel bioinspired nanoparticle. A VEGF‐inhibiting peptide was co‐assembled with Cu 2 + for stability and then modified with a reactive oxygen species (ROS) scavenger and a cell‐penetrating peptide. This multi‐functional design enables deep corneal penetration and targeted action. The resulting nanoparticle significantly prolongs ocular retention to 70 min. It achieved a remarkable penetration depth of 300 µm in a 3D corneal model, ensuring delivery to the site of disease. The nanoparticle demonstrated a dual mechanism of action; it effectively scavenged 60.31% of excess ROS and downregulated inflammation, reducing pro‐inflammatory macrophage polarization. This reshaped the immune microenvironment and potently suppressed angiogenesis, achieving 60.45% growth inhibition in the 3D model. In an animal model, the treatment successfully reduced abnormal blood vessel growth, with immunofluorescence confirming significantly lower expression of key inflammatory markers. This work presents a simple yet highly efficient strategy for deep ocular drug delivery, offering a potent therapeutic approach for CorNV and other oxidative stress‐ and inflammation‐related eye diseases.

Fields of Study & Subjects

Advanced Drug Delivery Systems Corneal Surgery and Treatments Nanoparticle-Based Drug Delivery

Publication details

Journal / source
Small
Volume
22
Issue
29
Pages
e14865–e14865
Publication date
30 March 2026
Language
EN